| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 22 | 84 | -1.82 | -0.24 | BLENDED GS |
| May 2025 | 71 | 85 | -4.77 | 0.90 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 22 | 84 | -1.82 | -0.24 | BLENDED GS |
| May 2025 | 71 | 85 | -4.77 | 0.90 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 356 | 113 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 113 | 356 | 6937 | 377 | 381 | 86 | 87 |
| May 2025 | 112 | 351 | 6771 | 377 | 381 | 86 | 87 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 113 | 356 | 6937 | 377 | 381 | 86 | 87 |
| May 2025 | 112 | 351 | 6771 | 377 | 381 | 86 | 87 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 343 | 285 | 228 | 179 | 134 |
| No. Herds | 100 | 97 | 93 | 83 | 67 |
| No. without completed record | 11 | 14 | 11 | 4 | 24 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 343 | 285 | 228 | 179 | 134 |
| No. Herds | 100 | 97 | 93 | 83 | 67 |
| No. without completed record | 11 | 14 | 11 | 4 | 24 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 356 | 113 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 0 | 0 | 0 | 0 |
| DFS | 0 | 0 | 0 | 0 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 298 | 37 | 347 | 43 |
| GER | 0 | 0 | 0 | 0 |
| ITA | 0 | 0 | 0 | 0 |
| NLD | 0 | 0 | 0 | 0 |
| NZL | 0 | 0 | 0 | 0 |
| USA | 0 | 0 | 0 | 0 |